The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
NCT01280825
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to collect DNA samples from patients undergoing routine care at the University of Chicago. These samples will be tested for differences in genes that may suggest greater risk of side effects or chance of increased benefit from certain medications. The results will be made available to the patient's treating physician and the researchers will track whether or not this information is used in routine health care.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Patients Undergoing Routine Health Care
- Heart Diseases
- Inflammatory Bowel Diseases
- Autoimmune Disease
- Inflammatory Disease
- Blood Coagulation Disorders
- Hepatitis C
- Non-Metastatic Neoplasm
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- University of Chicago
- Last updated on ClinicalTrials.gov
- March 4, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Illinois · 1
- University of Chicago Medical Center · Chicago, IL
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.